Stay up-to-date with the Sun Pharma Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a prominent stock. Explore the latest information on Sun Pharma, including: ...

Danish pharma giant says in process of challenging earlier verdict, where court allowed Dr Reddy’s to make and export ...

Earlier, the court had declined Novo’s plea for an interim injunction against Dr Reddy’s Labs and permitted the company to ...

Sun Pharma launches Ilumya (Tildrakizumab) in India, expanding its specialty medicines portfolio and bringing advanced ...

Sun Pharmaceutical Industries has announced the launch of its global innovative drug, Ilumya (tildrakizumab) in India for ...

Sun Pharma informed the stock exchanges that the board of directors of its subsidiary Sun Pharma Laboratories approved the ...

Pharma's post-Covid growth faces challenges as margin compression and strategic shifts emerge in 2026, urging a bottom-up ...

Morgan Stanley maintained its Overweight rating on Sun Pharma. The brokerage has set a target price of Rs 2,026, indicating a ...

Sun Pharma's managing director, Kirti Ganorkar, said Ilumya is already available in 35 countries and has consistently ...

TOKYO/MUMBAI (Reuters) - India's Sun Pharmaceutical Industries Ltd has agreed to buy generic drugmaker Ranbaxy Laboratories Ltd for $3.2 billion (1.9 billion pounds), betting it can fix factory ...

Sun Pharmaceutical Industries on Monday said it has launched its global innovative drug ILUMYA in India for the treatment of ...